-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

636.P1.38 636. Myelodysplastic Syndromes—Basic and Translational: Poster I

Symposia: Myelodysplastic Syndromes—Basic and Translational Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 10, 2022: 5:30 PM-7:30 PM
Hall D (Ernest N. Morial Convention Center)

Elena Riva1*, Matteo Zampini, PhD1*, Termanini Alberto, PhD2*, Lorenzo Dall'Olio, PhD3*, Alessandra Merlotti, PhD3*, Austin Kulasekararaj, MD, MBBS, FRCPath, MRCP4, Michela Calvi5*, Clara Di Vito, PhD5*, Daoud Rahal6*, Arturo Bonometti6*, Giorgio Croci7*, Emanuela Boveri8*, Umberto Gianelli, MD9*, Maurilio Ponzoni, MD10, Antonio Russo, MD1*, Benedetta Tinterri1*, Francesca Re1*, Elisabetta Sauta, PhD11*, Elena Saba1*, Erica Travaglino, BsC1*, Marta Ubezio, MD1*, Alessia Campagna1*, Luca Lanino12*, Giulia Maggioni, MD13*, Cristina Astrid Tentori, MD1*, Chiara Milanesi12*, Nicla Manes12*, Saverio D'Amico, MSc11*, Francesca Ficara, PhD14*, Laura Crisafulli15*, Domenico Mavilio5*, Enrico Lugli, PhD16*, Armando Santoro, MD17*, Maria Diez-Campelo, MD18*, Guillermo Sanz, MD, PhD19, Francesc Solé, PhD20, Uwe Platzbecker, MD21, Valeria Santini, MD, PhD22*, Shahram Kordasti, MD, PhD23, Pierre Fenaux24, Torsten Haferlach, MD25, Daniel Remondini, PhD3*, Castellani Gastone, PhD26* and Matteo G. Della Porta, MD27*

1Cancer Center, IRCCS Humanitas Research Hospital & Humanitas University, Rozzano, Italy
2Human Technopole, Milan, Italy
3Physics and Astronomy Department, University of Bologna, Bologna, Italy
4King’s College Hospital, National Institute for Health and Care Research/Wellcome King’s Clinical Research Facility, London, ENG, United Kingdom
5Unit of Clinical and Experimental Immunology, Humanitas Clinical and Research Center, Rozzano, Italy
6Pathology, IRCCS Humanitas Research Hospital, Rozzano - Milan, Italy
7Pathology Unit, Department of Pathophysiology and Transplantation, University of Milan and Fondazione IRCCS, Ca' Granda - Maggiore Policlinico, Italy, Milan, Italy
8Institute of Surgical Pathology, Pavia, PV, ITA
9University of Milan, Milan, Italy
10Pathology Unit, San Raffaele Scientific Institute, Milano, Italy
11Artificial Intelligence Center, Humanitas Research Hospital, Rozzano (Milan), Italy
12Cancer Center, IRCCS Humanitas Research Hospital & Humanitas University, Rozzano - Milan, Italy
13Cancer Center, IRCCS Humanitas Research Hospital & Humanitas University, Rozzano, MI, Italy
14IRCCS Humanitas Research Hospital & Humanitas University, Rozzano - Milan, MI, ITA
15IRCCS Humanitas Research Hospital & Humanitas University, Rozzano - Milan, ITA
16Humanitas Clinical and Research Center, Milan, MI, Italy
17Humanitas University and IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Milan, Italy
18Department of Hematology. Salamanca-IBSAL university hospital, Salamanca, salamanca, Spain
19Hematology Deparment, Health Research Institute La Fe, Valencia, Spain
20MDS Group. Institut de Recerca Contra la Leucèmia Josep Carreras (IJC), ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain
21Medical Clinical and Policlinic 1, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany
22Department of Experimental and Clinical Medicine, MDS Unit, Hematology, AOU Careggi - University of Florence, Firenze, Italy
23Systems Cancer Immunology, Comprehensive Cancer Centre, King's College London, London, United Kingdom
24Service d'Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France
25MLL Munich Leukemia Laboratory, Munich, Germany
26Department of Experimental, Diagnostic and Specialty Medicine - DIMES, University of Bologna, Bologna, Italy
27Cancer Center IRCCS Humanitas Research Hospital, Milan, Italy, Italy

Iva Trsová1,2*, Monika Belickova, PhD3,4*, Andrea Hrustincova2*, Monika Kaisrlikova, MSc5,6*, Zuzana Lenertova2,6*, David Kundrat2*, Zdenek Krejcik2*, Jitka Vesela2*, Jiri Klema7*, Petr Ryšavý8*, Jaroslav Cermak, MD, PhD9 and Michaela Dostalova Merkerova, PhD, MSc2*

1Faculty of Science, Charles University, Prague, Czech Republic
2Institute of Hematology and Blood Transfusion, Prague, Czech Republic
3Department of Genomics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
4Molecular Genetic, Prague, Czech Republic
5Institute of Hematology and Blood Transfusion, Prague, AL
6First Faculty of Medicine, Charles University, Prague, Czech Republic
7Czech Technical University, Prague, Czech Republic
8Department of Computer Science, Czech Technical University, Prague, Czech Republic
9Institute of Hematology and Blood Transfusion, Praha, Czech Republic

Sofia Bentivegna1*, Morten Holmstrøm2*, Alexander Balhuizen1,3*, Marwa Almosailleakh1*, Maria Perez-Penco2*, Bo Porse1,3*, Mads Hald Andersen2,4* and Kirsten Grønbæk1,5

1Biotech Research and Innovation Center (BRIC), University of Copenhagen, Copenhagen, Denmark
2National Center for Cancer Immune Therapy (CCIT-DK), University of Copenhagen, Copenhagen University Hospital Herlev, Herlev, Denmark
3The Finsen Laboratory, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
4Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark
5Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

Nanni Schmitt, MSc1*, Alexander Streuer, MD1*, Justine Danner1*, Eva Altrock, PhD1*, Vladimir Riabov, PhD1*, Qingyu Xu1*, Felicitas Rapp, PhD1*, Nadine Weimer1*, Iris Palme1*, Verena Nowak1*, Julia Obländer1*, Melda Göl1*, Ali Darwich, MD2*, Laurenz Steiner, MD1*, Tobias Boch, MD1*, Mohamad Jawhar, MD1*, Georgia Metzgeroth, MD1*, Wolf-Karsten Hofmann, MD1 and Daniel Nowak, MD1*

1Department of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
2Department of Orthopedics and Traumatology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany

Marie Schneider1*, Clara Rolfs1*, Matthias Trumpp1*, Susann Winter2*, Luise Fischer2*, Mandy Richter1*, Victoria Menger1*, Kolja Nenoff3*, Nora Grieb3*, Anne Sophie Kubasch, MD4*, Klaus H. Metzeler, MD1, Katja Sockel, MD2*, Christian Thiede, MD5, Lorenz C Hofbauer6*, Andreas Roth7*, Andreas Bruederle8*, Janghee Woo, MD, PhD9, Michael Cross1* and Uwe Platzbecker, MD10

1Department of Hematology and Cell Therapy, University Hospital Leipzig, Leipzig, Germany
2Department of Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany
3Department of Hematology, Cell Therapy and Hemostaseology, University Hospital Leipzig, Leipzig, Germany
4Department of Hematology, Cellular Therapy and Hemostaseology, Department of Hematology and Cell Therapy, Medical Clinic and Policlinic I, Leip, Leipzig, Germany
5Department of Internal Medicine I, University Hospital Dresden, Dresden, Germany
6Department of Medicine III, University Hospital Carl Gustav Carus, Dresden, Germany
7Department of Orthopedic Surgery, University Hospital Leipzig, Leipzig, Germany
8Novartis Oncology, Basel, Switzerland
9Novartis Institutes for BioMedical Research, Cambridge, MA
10Medical Clinical and Policlinic 1, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany

Teodora Kuzmanovic1*, Metis Hasipek, PhD2*, Samuel Li, BA3*, Thomas Laframboise, PhD3*, Valeria Visconte, PhD4, Sunisa Kongkiatkamon, MD5*, Seth J. Corey, MD6, Sudipto Mukherjee, MD, PhD, MPH7, Anjali Advani, MD8, Aaron T. Gerds, MD, MS9, Yogenthiran Saunthararajah, MD4, Sophia R. Balderman, MD10, Abhay Singh, MD, MPH11, Hetty E. Carraway, MD, MBA7, Niroshan Nadarajah12*, Manja Meggendorfer, PhD13, Jaroslaw P. Maciejewski, MD, PhD, FACP14 and Bhumika J. Patel, MD15

1Leukemia Program, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
2Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
3Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH
4Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
5Department of Translational Hematology and Oncology Research, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH
6Departments of Pediatrics and Cancer Biology, Cleveland Clinic, Cleveland, OH
7Department of Hematology and Medical Oncology, Taussig Cancer institute, Leukemia Program, Cleveland Clinic, Cleveland, OH
8Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
9Department of Hematology and Medical Oncology,, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
10Taussig Cancer Institute, Cleveland Clinic, Cleveland
11Department of Hematology and Medical Oncology, Taussig Cancer Institute, Leukemia Program, Cleveland Clinic Foundation, Cleveland, OH
12MLL Munich Leukemia Laboratory, Munich, Germany
13MLL Munich Leukemia Laboratory, Munich, Bavaria, Germany
14Translational Hematology and Oncology Research, Cleveland Clinic Foundation/ Taussig Cancer Institute, Cleveland, OH
15Prisma Health - University Medical Group - University of South Carolina School of Medicine Greenville, Greenville, SC

Bruno Fattizzo, MD1*, Cristina Vercellati2*, Anna Marcello3*, Marta Bortolotti, MD4,5*, Anna Zaninoni, BSc6*, Elisa Fermo7*, Paola Bianchi, PhD, BSc7 and Wilma Barcellini, MD8*

1University of Milan, Milan, Italy
2UOC Ematologia, UOS Fisiopatologia delle Anemie, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy
3Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, ITA
4Department of Oncology and Oncohaematology, University of Milan, Milan, Italy
5Haematology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
6Hematology Unit, Pathophysiology of Anemias Unit, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy, Italy
7Hematology Unit, Pathophysiology of Anemias Unit, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
8Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy

Yingwan Luo, Ph.D1*, Xiaomin Feng, MD, PhD2*, Wei Lang, M.S.3*, Chen Mei4*, Rongzhen Xu, PhD5*, Gang Huang, PhD6 and Hongyan Tong, MD, PhD7*

1Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
2Divisions of Pathology and Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
3The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
4Department of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
5Hematology, The Second Affiliated Hospital of Zhejiang University School of Medcine, Hangzhou, China
6Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
7Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, PR China, Hangzhou, China

Monika Kaisrlikova, MSc1,2*, Iva Trsová1,3*, Zuzana Lenertova1,2*, Jitka Vesela1*, David Kundrat1*, Hana Votavova, PhD1*, Michaela Dostalova Merkerova, PhD, MSc1*, Zdenek Krejcik1*, Martin Vostry1*, Jaroslav Cermak, MD, PhD4 and Monika Belickova, PhD1*

1Institute of Hematology and Blood Transfusion, Prague, Czech Republic
2First Faculty of Medicine, Charles University, Prague, Czech Republic
3Faculty of Science, Charles University, Prague, Czech Republic
4Institute of Hematology and Blood Transfusion, Praha, Czech Republic

Takuto Mori, MD1,2*, Yotaro Ochi, MD, PhD1,2*, Ayana Kon, MD, PhD1*, Tetsuichi Yoshizato, MD, PhD1, Haruhiko Koseki, MD, PhD3*, Manabu Nakayama, PhD4*, Akinori Yoda, PhD5*, Masahiro Marshall Nakagawa, MD, PhD1, June Takeda, MD1*, Ryunosuke Saiki1*, Rurika Okuda, MSc, BS1*, Yasunobu Nagata, MD, PhD1*, Kenichi Yoshida1, Masashi Sanada, MD, PhD1, Hideki Makishima, MD, PhD1, Akifumi Takaori-Kondo, MD, PhD2, Jaroslaw P. Maciejewski, MD, PhD, FACP6, Yoshiko Atsuta7*, Torsten Haferlach, MD8, Yasuhito Nannya, MD, PhD1 and Seishi Ogawa, MD, PhD1

1Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
2Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
3Laboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
4Kazusa DNA Research Institute, Kisarazu, JPN
5Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto City, Japan
6Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
7Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan
8MLL Munich Leukemia Laboratory, Munich, Germany

Antonieta Molero Yordi, MD1*, Soraya Peralta2*, Laura Gallur, MD3*, Bárbara Tazón, PhD1*, Víctor Navarro Garcés4*, Silvia Saumell, MD, PhD5*, Maria Julia Montoro, MD, PhD3*, Olga Salamero, MD1*, Ana Pérez González, MD5*, Sara Garrido, MD1*, Maria Sola, MD1*, Tamara Jimenez6*, Félix López Cadenas, MD7*, Teresa Ezponda8*, Ana Alfonso-Pierola, MD, PhD8*, Lídia Altimiras9*, Maria Diez-Campelo, MD10*, Felipe Prosper, MD11* and David Valcárcel, MD, PhD5

1Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
2Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
3Department of Hematology, University Hospital Vall d’Hebron, University Autonoma of Barcelona (UAB), Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
4Oncology Data Science (ODysSey) Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
5Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), University Autonoma of Barcelona (UAB), Barcelona, Spain
6Department of Hematology. Salamanca-IBSAL university hospital, Salamanca, Spain
7Department of Hematology. Salamanca-IBSAL university hospital, SALAMANCA, SALAMANCA, Spain
8Department of Oncology-Hematology, Centro de Investigación Médica Aplicada (CIMA), Navarra university-IDISNA. Centro de Investigación Biomédica en Red de Cáncer, CIBERONC. Clínica Universidad de Navarra, Pamplona, Spain
9Department of Hematology, University Hospital Vall d’Hebron, University Autonoma of Barcelona (UAB), Barcelona, Spain
10Department of Hematology. Salamanca-IBSAL university hospital, Salamanca, salamanca, Spain
11Department of Oncology-Hematology, Centro de Investigación Médica Aplicada (CIMA), Navarra university-IDISNA. Centro de Investigación Biomédica en Red de Cáncer, CIBERONC. Clínica Universidad de Navarra, Pamplona, Navarra, Spain

Jinming Song, MD, PhD1*, Lynn C. Moscinski, MD1, Ethan Yang2*, Mohammad Hussaini, MD1* and Hailing Zhang, MD1*

1H. Lee Moffitt Cancer Center and Research Institute, Department of Pathology, Tampa
2Berkey Preparatory School of Tampa, Tampa, FL

Manja Wobus, PhD1*, Ekaterina Balaian, MD1,2*, Triantafyllos Chavakis3,4*, Alexander Funk5*, Thomas Krüger6*, Uwe Platzbecker, MD7, Marie Törngren8*, Helena Eriksson, PhD9*, Eva Bondesson, PhD9*, Martin Bornhäuser, MD10,11,12* and Katja Sockel, MD1,13*

1Department of Medicine I, University Hospital Carl Gustav Carus Dresden, Dresden, Germany
2German Cancer Consortium (DKTK), Partner Site Dresden and German Cancer Research Center (DKFZ), Dresden, Saxony, Germany
3Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Dresden, Dresden, Germany
4National Center for Tumor Diseases, Partner Site Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany
5Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus Dresden, Dresden, Germany
6Department of Medicine 1, University Hospital TU Dresden, Dresden, DEU
7Medical Clinical and Policlinic 1, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany
8Active Biotech AB, Lund, Sweden
9Active Biotech, Lund, Sweden
10National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany
11Department of Internal Medicine I, University Hospital Dresden, Dresden, Germany
12German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany
13German Cancer Consortium (DKTK), Partner Site Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany

Anna Brown, PhD1, Claire Homan, PhD1*, Michael W. Drazer, MD, PhD2,3*, Kai Yu, PhD4*, David Lawrence5*, Jinghua Feng, PhD6*, Luis Arriola-Martinez7*, Matthew Pozsgai8*, Kelsey McNeely8*, Thuong Ha, PhD9*, Parvathy Venugopal, PhD1, Peer Arts, PhD10*, Sarah King-Smith11*, Jesse JC Cheah1*, Mark Armstrong, MSc12*, Csaba Bödör, PhD13*, Paul Wang1*, Alan B. Cantor, MD14, Mario Cazzola, MD15, Erin Degelman, MSc, BSc16*, Courtney D. DiNardo, MD, MSCE17, Nicolas Duployez, PharmD, PhD18,19*, Remi Favier20*, Stefan Fröhling, MD21, Ana Rio-Machin, PhD22*, Jeffery M. Klco, MD, PhD23, Alwin Krämer, MD24*, Mineo Kurokawa25*, Joanne Lee, MBBS26*, Luca Malcovati, MD27, Neil V Morgan28*, Georges Natsoulis, Ph.D.29*, Carolyn Owen, MD30, Keyur P. Patel, MBBS, PhD31, Claude Preudhomme, PharmD, PhD32, Hana Raslova33*, Hugh Young Rienhoff Jr., MD29, Tim Ripperger, MD, PhD34*, Rachael Schulte, MD, MS35*, Kiran Tawana, MD36*, Elvira Deolinda Rodrigues Pereira Velloso, MD, PhD37, Benedict Yan, MBBS38*, Raman Sood, PhD39*, Amy Hsu40*, Steven M. Holland, MD41*, Kerry Phillips42*, Nicola Poplawski, MD42*, Milena Babic, BMPharBio (Hons)10*, Erika M Kwon Kim, PhD43*, Andrew H. Wei, MBBS, FRACP, FRCPA, PhD44, Cecily Forsyth, MBBS, FRACP, FRCPA45, Helen Mar Fan, MD46*, Ian D Lewis, MBBS, PhD47, Julian Cooney, MBBS, FRACP, FRCPA48, Rachel Susman49*, Lucy C. Fox, MBBS50, Piers Blombery, MBBS51, Deepak Singhal, MBBS, MD, FRCPA, FRACP52*, Devendra Hiwase, MD, MBBS, PhD, FRACP, FRCPA52, Andreas W Schreiber, PhD53*, Christopher N Hahn, PhD1, Hamish S Scott, PhD1, Paul P. Liu, MD, PhD54 and Lucy A. Godley, MD, PhD3

1Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, Australia
2Section of Hematology/Oncology, The University of Chicago, Chicago, IL
3The University of Chicago Comprehensive Cancer Center, The University of Chicago, Chicago
4NHGRI, NHGRI, Bethesda, MD
5ACRF Cancer genomics facility, Centre for Cancer Biology, SA Pathology, Adelaide, Australia
6ACRF Cancer Genomics Facility, SA Pathology, Adelaide, Australia
7Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, AUS
8Department of Medicine, Section of Hematology-Oncology, The University of Chicago, Chicago, IL
9Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, AUS
10Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia
11Centre For Cancer Biology, SA Pathology and University of South Australia, Adelaide, AUS
12Molecular Oncology, Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, Australia
13HCEMM-SE Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary
14Division of Pediatric Hematology-Oncology, Boston Childrens Hospital, Boston, MA
15University of Pavia, University of Pavia, Pavia, Italy
16Division of Hematology and Hematological Malignancies, Foothills Medical Centre, Calgary, Canada
17Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
18University of Lille, Lille, France
19Cancer Research Institute, INSERM Unité Mixte de Recherche (UMR)-S 1172, F-59000 Lille, CHU Lille, Laboratory of Hematology, F-59000 Lille, Lille, France
20Assistance Publique ? Hôpitaux De Paris, Paris, FRA
21National Center for Tumor Diseases (NCT), Heidelberg, Germany
22Barts Cancer Institute, Queen Mary University of London, London, United Kingdom
23Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
24Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Department of Internal Medicine V, Heidelberg, Germany
25Graduate School of Medicine, The University of Tokyo, Bunkyo-Ku, Tokyo, JPN
26National University Health System, National University Cancer Institute, Singapore, Singapore
27Department of Molecular Medicine, University of Pavia, Pavia, Italy, Pavia, Italy, Pavia, Italy
28Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom
29Imago BioSciences, San Carlos, CA
30Foothills Medical Centre Division of Hematology and Hematological Malignancies, Calgary, AB, Canada
31Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
32Laboratory of Hematology, Centre Hospitalier Universitaire Lille, Lille, France
33INSERM, UMR1287, Gustave Roussy, Université Paris-Saclay, Equipe labellisée Ligue Nationale Contre le Cancer, Equipe GRex, Villejuif, France
34Department of Human Genetics, Hannover Medical School, Hannover, Germany
35Monroe Carell Jr. Children’s Hospital, Vanderbilt University Medical Center, Nashville, TN
36Department of Haematology, Addenbrooke’s Hospital, Cambridge, United Kingdom
37Division of Hematology, Hospital das Clínicas , São Paulo Medical School, University of São Paulo, São Paulo, Brazil
38Molecular Diagnosis Centre, Department of Laboratory Medicine, National University Hospital, Singapore, Singapore, Singapore
39NHGRI, NIH, Bethesda, MD
40National Institutes of Health, Bethesda, MD
41National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
42Adult Genetics Unit, Royal Adelaide Hospital, Adelaide, Australia
43NCI, NIH, Rockville, MD
44The Alfred Hospital and Monash University, Melbourne, VIC, Australia
45Central Coast Haematology, North Gosford, Australia
46Genetic Health Queensland, Brisbane, Australia
47Adelaide Oncology and Haematology, North Adelaide, Australia
48Department of Haematology, Fiona Stanley Hospital, Perth, Australia
49Queensland Genetic Health, Brisbane, Australia
50Peter MacCallum Cancer Centre, Melbourne, Australia
51Peter MacCallum Cancer Centre, Peter Maccallum Cancer Centre, East Melbourne, VIC, Australia
52Department of Haematology, SA Pathology, Adelaide, Australia
53ACRF Cancer Genomics Facility, Adelaide, Australia
54Translational and Functional Genomics Branch, National Human Genome Research Institute, NIH, Bethesda, MD

*signifies non-member of ASH